Temelimab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Temelimab, covering 2024-05-17 to 2024-11-07. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis [Phase 2]